Katzenell Dimant represents Kitov Pharmaceuticals Holdings Ltd. in publishing a prospectus for public issuance of its securities and registration of such securities for trade on the Tel Aviv Stock Exchange.
Kitov Pharmaceuticals is an innovative biopharmaceutical company focused on late-stage drug development.